Related Experiment Videos
DNA topoisomerase II as a target for cancer chemotherapy
Jerrylaine V Walker1, John L Nitiss
1Department of Molecular Pharmacology, St. Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105, USA.
Cancer Investigation
|July 4, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A multispecies toolkit of TOP2 hypercleavage mutants for studying topoisomerase II-mediated DNA damage.
Proceedings of the National Academy of Sciences of the United States of America·2026
A multi-species toolkit of TOP2 hypercleavage mutants for studying topoisomerase II-mediated DNA damage.
bioRxiv : the preprint server for biology·2026
Yeast Tools for Studying Type II Topoisomerases in Budding Yeast.
Methods in molecular biology (Clifton, N.J.)·2025
Genome Instability Induced by Topoisomerase Misfunction.
International journal of molecular sciences·2024
Modeling allosteric mechanisms of eukaryotic type II topoisomerases.
Biophysical journal·2024
RAD54L2 counters TOP2-DNA adducts to promote genome stability.
Science advances·2023
ANAPC7 promotes triple-negative breast cancer progression through ANAPC2-dependent degradation of PCGF2 and activation of STAT3.
Molecular cancer research : MCR·2026
pH-Responsive drug delivery system for tumor therapy.
Nanoscale·2026
Spatiotemporally controlled degradation of CDK6 via light-triggered ROS generation: uncovering the proximity effect-mediated dual target depletion.
Organic & biomolecular chemistry·2026
Targeting RAS for Pancreatic Cancer Interception.
Cancer discovery·2026